Header

UZH-Logo

Maintenance Infos

Browse by Creators

Navigate back| Up a level
Export as
Number of items: 166.

Braun, Ralph P; Mangana, Johanna; Goldinger, Simone M; French, Lars; Dummer, Reinhard; Marghoob, Ashfaq A (2017). Electrical impedance spectroscopy in skin cancer diagnosis. Dermatologic Clinics, 35(4):489-493.

Ramelyte, Egle; Koelblinger, Peter; Dummer, Reinhard (2017). Oestrogen receptor expression in melanoma. Journal of the European Academy of Dermatology and Venerology, 31(9):1399-1400.

Izar, Benjamin; Sharfman, William; Hodi, F Stephen; Lawrence, Donald; Flaherty, Keith T; Amaravadi, Ravi; Kim, Kevin B; Puzanov, Igor; Sosman, Jeffrey; Dummer, Reinhard; Goldinger, Simone M; Lam, Lyhping; Kakar, Shefali; Tang, Zhongwen; Krieter, Oliver; McDermott, David F; Atkins, Michael B (2017). A first-in-human phase I, multicenter, open-label, dose-escalation study of the oral RAF/VEGFR-2 inhibitor (RAF265) in locally advanced or metastatic melanoma independent from BRAF mutation status. Cancer Medicine, 6(8):1904-1914.

Koelblinger, Peter; Dornbierer, Joelle; Dummer, Reinhard (2017). A review of binimetinib for the treatment of mutant cutaneous melanoma. Future Oncology (London, England), 13(20):1755-1766.

Frauchiger, Anna L; Brüggen, Marie-Charlotte; Goldinger, Simone M; Dummer, Reinhard (2017). Interstitial granulomatous dermatitis during talimogen laherparepvec treatment. Melanoma research, 27(4):400-401.

Dummer, Reinhard; Ramelyte, Egle; Schindler, Sabrina; Thürigen, Olaf; Levesque, Mitchell P; Koelblinger, Peter (2017). MEK inhibition and immune responses in advanced melanoma. OncoImmunology, 6(8):e1335843.

Mangana, Joanna; Cheng, Phil F; Kaufmann, Corina; Amann, Valerie C; Frauchiger, Anna L; Stögner, Viola; Held, Ulrike; von Moos, Roger; Michielin, Olivier; Braun, Ralph P; Levesque, Mitchell P; Goldinger, Simone M; Dummer, Reinhard (2017). Multicenter, real-life experience with checkpoint inhibitors and targeted therapy agents in advanced melanoma patients in Switzerland. Melanoma research, 27(4):358-368.

Murer, Carla; Kränzlin-Stieger, Pascale; French, Lars E; Dummer, Reinhard; Goldinger, Simone M (2017). Successful treatment with imatinib after nilotinib and ipilimumab in a c-kit-mutated advanced melanoma patient: a case report. Melanoma research, 27(4):396-398.

Smith, Michael P; Rowling, Emily J; Miskolczi, Zsofia; Ferguson, Jennifer; Spoerri, Loredana; Haass, Nikolas K; Sloss, Olivia; McEntegart, Sophie; Arozarena, Imanol; von Kriegsheim, Alex; Rodriguez, Javier; Brunton, Holly; Kmarashev, Jivko; Levesque, Mitchell P; Dummer, Reinhard; Frederick, Dennie T; Andrews, Miles C; Cooper, Zachary A; Flaherty, Keith T; Wargo, Jennifer A; Wellbrock, Claudia (2017). Targeting endothelin receptor signalling overcomes heterogeneity driven therapy failure. EMBO Molecular Medicine, 9(8):1011-1029.

Schadendorf, Dirk; et al; Dummer, Reinhard (2017). Health-related quality of life results from the phase III CheckMate 067 study. European Journal of Cancer, 82:80-91.

Delord, Jean-Pierre; Robert, Caroline; Nyakas, Marta; McArthur, Grant A; Kudchakar, Ragini; Mahipal, Amit; Yamada, Yasuhide; Sullivan, Ryan J; Arance, Ana; Kefford, Richard F; Carlino, Matteo S; Hidalgo, Manuel; Gomez-Roca, Carlos; Michel, Daniela; Seroutou, Abdelkader; Aslanis, Vassilios; Caponigro, Giordano; Stuart, Darrin; Moutouh-de Parseval, Laure; Demuth, Tim; Dummer, Reinhard (2017). Phase I Dose-Escalation and -Expansion Study of the BRAF Inhibitor Encorafenib (LGX818) in Metastatic BRAF-Mutant Melanoma. Clinical Cancer Research:1-38.

Prince, H Miles; Kim, Youn H; Horwitz, Steven M; et al; Dummer, Reinhard (2017). Brentuximab vedotin or physician's choice in CD30-positive cutaneous T-cell lymphoma (ALCANZA): an international, open-label, randomised, phase 3, multicentre trial. Lancet, 390(10094):555-566.

Tumeh, Paul C; Hellmann, Matthew D; et al; Dummer, Reinhard (2017). Liver Metastasis and Treatment Outcome with Anti-PD-1 Monoclonal Antibody in Patients with Melanoma and NSCLC. Cancer Immunology Research, 5(5):417-424.

Nosrati, Adi; Tsai, Katy K; Goldinger, Simone M; Tumeh, Paul; Grimes, Barbara; Loo, Kimberly; Algazi, Alain P; Nguyen-Kim, Thi Dan Linh; Levesque, Mitchell; Dummer, Reinhard; Hamid, Omid; Daud, Adil (2017). Evaluation of clinicopathological factors in PD-1 response: derivation and validation of a prediction scale for response to PD-1 monotherapy. British Journal of Cancer, 116(9):1141-1147.

Dummer, Reinhard; Ramelyte, Egle; Levesque, Mitch; Goldinger, Simone M; Braun, Ralph P (2017). Critical aspects to achieve a high-quality melanoma clinic. Current Opinion in Oncology, 29(2):145-150.

Coens, Corneel; Suciu, Stefan; Chiarion-Sileni, Vanna; Grob, Jean-Jacques; Dummer, Reinhard; Wolchok, Jedd D; Schmidt, Henrik; Hamid, Omid; Robert, Caroline; Ascierto, Paolo A; Richards, Jon M; Lebbé, Celeste; Ferraresi, Virginia; Smylie, Michael; Weber, Jeffrey S; Maio, Michele; Bottomley, Andrew; Kotapati, Srividya; de Pril, Veerle; Testori, Alessandro; Eggermont, Alexander M M (2017). Health-related quality of life with adjuvant ipilimumab versus placebo after complete resection of high-risk stage III melanoma (EORTC 18071): secondary outcomes of a multinational, randomised, double-blind, phase 3 trial. Lancet Oncology, 18(3):393-403.

Ramelyte, Egle; Schindler, Sabrina A; Dummer, Reinhard (2017). The safety of anti PD-1 therapeutics for the treatment of melanoma. Expert Opinion on Drug Safety, 16(1):41-53.

Harrington, Kevin J; Michielin, Olivier; Malvehy, Josep; Grove, Lorna; Frauchiger, Anna Lisa; Dummer, Reinhard (2017). A practical guide to the handling and administration of talimogene laherparepvec in Europe. Oncotargets and Therapy, 10:3867-3880.

Mangana, Joanna; Guenova, Emmanuella; Kerl, Katrin; Urosevic-Maiwald, Mirjana; Amann, Valerie C; Bayard, Cornelia; Dummer, Reinhard; French, Lars E (2017). Angioimmunoblastic T-Cell Lymphoma Mimicking Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS Syndrome). Case Reports in Dermatology, 9(1):74-79.

Dummer, Reinhard; Schadendorf, Dirk; Ascierto, Paolo A; Arance, Ana; Dutriaux, Caroline; Di Giacomo, Anna Maria; Rutkowski, Piotr; Del Vecchio, Michele; Gutzmer, Ralf; Mandala, Mario; Thomas, Luc; Demidov, Lev; Garbe, Claus; Hogg, David; Liszkay, Gabriella; Queirolo, Paola; Wasserman, Ernesto; Ford, James; Weill, Marine; Sirulnik, L Andres; Jehl, Valentine; Bozón, Viviana; Long, Georgina V; Flaherty, Keith (2017). Binimetinib versus dacarbazine in patients with advanced NRAS -mutant melanoma (NEMO): a multicentre, open-label, randomised, phase 3 trial. Lancet Oncology, 18(4):435-445.

Bossart, Simon; Thurneysen, Selina; Rushing, Elisabeth; Frontzek, Karl; Leske, Henning; Mihic‐Probst, Daniela; Nagel, Hannes W; Mangana, Johanna; Goldinger, Simone M; Dummer, Reinhard (2017). Case Report: Encephalitis, with Brainstem Involvement, Following Checkpoint Inhibitor Therapy in Metastatic Melanoma. The oncologist, 22(6):749-753.

Dummer, Reinhard; Hoeller, Christoph; Gruter, Isabella Pezzani; Michielin, Olivier (2017). Combining talimogene laherparepvec with immunotherapies in melanoma and other solid tumors. Cancer Immunology, Immunotherapy, 66(6):683-695.

Binkert, Andrea; Dummer, Reinhard (2017). Dermatoonkologie – was kann in der Hausarztpraxis angeboten werden? Praxis, 106(9):471-475.

Haueis, Silvia A; Kränzlin, Pascale; Mangana, Joanna; Cheng, Phil F; Urosevic-Maiwald, Mirjana; Braun, Ralph P; Levesque, Mitchell P; Dummer, Reinhard; Goldinger, Simone M (2017). Does the distribution pattern of brain metastases during BRAF inhibitor therapy reflect phenotype switching? Melanoma research, 27(3):231-237.

Trautinger, Franz; Eder, Johanna; Assaf, Chalid; Bagot, Martine; Cozzio, Antonio; Dummer, Reinhard; Gniadecki, Robert; Klemke, Claus-Detlev; Ortiz-Romero, Pablo L; Papadavid, Evangelia; Pimpinelli, Nicola; Quaglino, Pietro; Ranki, Annamari; Scarisbrick, Julia; Stadler, Rudolf; Väkevä, Liisa; Vermeer, Maarten H; Whittaker, Sean; Willemze, Rein; Knobler, Robert (2017). European Organisation for Research and Treatment of Cancer consensus recommendations for the treatment of mycosis fungoides/Sézary syndrome – Update 2017. European Journal of Cancer, 77:57-74.

Jaberg-Bentele, Nicoletta; Kunz, Michael; Dummer, Reinhard; Abuhammad, Shatha (2017). Flare-up of rheumatoid arthritis by Anti-CTLA-4 antibody but not by Anti-PD1 therapy in a patient with metastatic melanoma. Case Reports in Dermatology, 9(1):65-68.

Behera, Reeti; Kaur, Amanpreet; Webster, Marie R; Kim, Suyeon; Ndoye, Abibatou; Kugel, Curtis H; Alicea, Gretchen M; Wang, Joshua X; Ghosh, Kanad; Cheng, Phil F; Lisanti, Sofia; Marchbank, Katie; Dang, Vanessa; Levesque, Mitchell Paul; Dummer, Reinhard; Xu, Xiaowei; Heryn, Meenhard; Aplin, Andrew E; Roesch, Alexander; Caino, M. Cecilia; Altieri, Dario C; Weeraratna, Ashani T (2017). Inhibition of age-related therapy resistance in melanoma by rosiglitazone-mediated induction of Klotho. Clinical Cancer Research, 23(12):3181-3190.

Levesque, Mitchell P; Cheng, Phil F; Raaijmakers, Marieke I G; Saltari, Annalisa; Dummer, Reinhard (2017). Metastatic melanoma moves on: translational science in the era of personalized medicine. Cancer Metastasis Reviews, 36(1):7-21.

Long, Georgina V; Weber, Jeffrey S; Larkin, James; Atkinson, Victoria; Grob, Jean-Jacques; Schadendorf, Dirk; Dummer, Reinhard; Robert, Caroline; Márquez-Rodas, Ivan; McNeil, Catriona; Schmidt, Henrik; Briscoe, Karen; Baurain, Jean-François; Hodi, F Stephen; Wolchok, Jedd D (2017). Nivolumab for Patients With Advanced Melanoma Treated Beyond Progression: Analysis of 2 Phase 3 Clinical Trials. JAMA Oncology:Epub ahead of print.

Ribas, Antoni; Dummer, Reinhard; Puzanov, Igor; VanderWalde, Ari; Andtbacka, Robert H I; Michielin, Olivier; Olszanski, Anthony J; Malvehy, Josep; Cebon, Jonathan; Fernandez, Eugenio; Kirkwood, John M; Gajewski, Thomas F; Chen, Lisa; Gorski, Kevin S; Anderson, Abraham A; Diede, Scott J; Lassman, Michael E; Gansert, Jennifer; Hodi, F Stephen; Long, Georgina V (2017). Oncolytic Virotherapy Promotes Intratumoral T Cell Infiltration and Improves Anti-PD-1 Immunotherapy. Cell, 170(6):1109-1119.e10.

Farsam, Vida; Basu, Abhijit; Gatzka, Martina; Treiber, Nicolai; Schneider, Lars A; Mulaw, Medhanie A; Lucas, Tanja; Kochanek, Stefan; Dummer, Reinhard; Levesque, Mitchell P; Wlaschek, Meinhard; Scharffetter-Kochanek, Karin (2016). Senescent fibroblast-derived Chemerin promotes squamous cell carcinoma migration. OncoTarget, 7(50):83554-83569.

Eggermont, A M M; Suciu, S; Rutkowski, Piotr; Kruit, Willem H; Punt, Cornelis J; Dummer, Reinhard; Salès, Francois; Keilholz, Ulrich; De Schaetzen, Gaetan; Testori, Alessandro (2016). Long term follow up of the EORTC 18952 trial of adjuvant therapy in resected stage IIBeIII cutaneous melanoma patients comparing intermediate doses of interferon-alpha-2b (IFN) with observation: Ulceration of primary is key determinant for IFN-sensitivity. European Journal of Cancer, 55:111-121.

Dirschka, Thomas; Gupta, Girish; Micali, Giuseppe; Stockfleth, Eggert; Basset-Séguin, Nicole; Del Marmol, Véronique; Dummer, Reinhard; Jemec, Gregor B E; Malvehy, Josep; Peris, Ketty; Puig, Susana; Stratigos, Alexander J; Zalaudek, Iris; Pellacani, Giovanni (2016). Real-world approach to actinic keratosis management: Practical treatment algorithm for office-based dermatology. Journal of Dermatological Treatment:1-50.

Raaijmakers, Marieke I G; Widmer, Daniel S; Narechania, Apurva; Eichhoff, Ossia; Freiberger, Sandra N; Wenzina, Judith; Cheng, Phil F; Mihic-Probst, Daniela; Desalle, Rob; Dummer, Reinhard; Levesque, Mitchell P (2016). Co-existence of BRAF and NRAS driver mutations in the same melanoma cells results in heterogeneity of targeted therapy resistance. OncoTarget, 7(47):77163-77174.

Eggermont, Alexander M M; Chiarion-Sileni, Vanna; Grob, Jean-Jacques; Dummer, Reinhard; Wolchok, Jedd D; Schmidt, Henrik; Hamid, Omid; Robert, Caroline; Ascierto, Paolo A; Richards, Jon M; Lebbé, Céleste; Ferraresi, Virginia; Smylie, Michael; Weber, Jeffrey S; Maio, Michele; Bastholt, Lars; Mortier, Laurent; Thomas, Luc; Tahir, Saad; Hauschild, Axel; Hassel, Jessica C; Hodi, F Stephen; Taitt, Corina; de Pril, Veerle; de Schaetzen, Gaetan; Suciu, Stefan; Testori, Alessandro (2016). Prolonged survival in stage III melanoma with ipilimumab adjuvant therapy. New England Journal of Medicine, 375(19):1845-1855.

Czyż, Małgorzata; Toma, Monika; Gajos-Michniewicz, Anna; Majchrzak, Kinga; Hoser, Grazyna; Szemraj, Janusz; Nieborowska-Skorska, Margaret; Cheng, Phil; Gritsyuk, Daniel; Levesque, Mitchell; Dummer, Reinhard; Sliwinski, Tomasz; Skorski, Tomasz (2016). PARP1 inhibitor olaparib (Lynparza) exerts synthetic lethal effect against ligase 4-deficient melanomas. OncoTarget, 7(46):75551-75560.

Schadendorf, Dirk; Dummer, Reinhard; Hauschild, Axel; Robert, Caroline; Hamid, Omid; Daud, Adil; van den Eertwegh, Alfons; Cranmer, Lee; O'Day, Steven; Puzanov, Igor; Schachter, Jacob; Blank, Christian; Salama, April; Loquai, Carmen; Mehnert, Janice M; Hille, Darcy; Ebbinghaus, Scot; Kang, S Peter; Zhou, Wei; Ribas, Antoni (2016). Health-related quality of life in the randomised KEYNOTE-002 study of pembrolizumab versus chemotherapy in patients with ipilimumab-refractory melanoma. European Journal of Cancer, 67:46-54.

Lacouture, Mario E; Dréno, Brigitte; Ascierto, Paolo Antonio; Dummer, Reinhard; Basset-Seguin, Nicole; Fife, Kate; Ernst, Scott; Licitra, Lisa; Neves, Rogerio I; Peris, Ketty; Puig, Susana; Sokolof, Jonas; Sekulic, Aleksandar; Hauschild, Axel; Kunstfeld, Rainer (2016). Characterization and management of hedgehog pathway inhibitor-related adverse events in patients with advanced basal cell carcinoma. The oncologist, 21(10):1218-1229.

Imhof, Laurence; Dummer, Reinhard; Dreier, Jil; Kolm, Isabel; Barysch, Marjam J (2016). A Prospective Trial Comparing Q-Switched Ruby Laser and a Triple Combination Skin-Lightening Cream in the Treatment of Solar Lentigines. Dermatologic Surgery, 42(7):853-7.

Dummer, Reinhard; Guminski, Alexander; Gutzmer, Ralf; Dirix, Luc; Lewis, Karl D; Combemale, Patrick; Herd, Robert M; Kaatz, Martin; Loquai, Carmen; Stratigos, Alexander J; Schulze, Hans-Joachim; Plummer, Ruth; Gogov, Sven; Pallaud, Celine; Yi, Tingting; Mone, Manisha; Chang, Anne Lynn S; Cornélis, Frank; Kudchadkar, Ragini; Trefzer, Uwe; Lear, John T; Sellami, Dalila; Migden, Michael R (2016). The 12-month analysis from Basal Cell Carcinoma Outcomes with LDE225 Treatment (BOLT): A phase II, randomized, double-blind study of sonidegib in patients with advanced basal cell carcinoma. Journal of the American Academy of Dermatology:113-125.

Huber, Roman; Meier, Barbara; Otsuka, Atsushi; Fenini, Gabriele; Satoh, Takashi; Gehrke, Samuel; Widmer, Daniel; Levesque, Mitchell P; Mangana, Joanna; Kerl, Katrin; Gebhardt, Christoffer; Fujii, Hiroko; Nakashima, Chisa; Nonomura, Yumi; Kabashima, Kenji; Dummer, Reinhard; Contassot, Emmanuel; French, Lars E (2016). Tumour hypoxia promotes melanoma growth and metastasis via High Mobility Group Box-1 and M2-like macrophages. Scientific Reports, 6:29914.

Zimmer, Lisa; Goldinger, Simone M; Hofmann, Lars; Loquai, Carmen; Ugurel, Selma; Thomas, Ioannis; Schmidgen, Maria I; Gutzmer, Ralf; Utikal, Jochen S; Göppner, Daniela; Hassel, Jessica C; Meier, Friedegund; Tietze, Julia K; Forschner, Andrea; Weishaupt, Carsten; Leverkus, Martin; Wahl, Renate; Dietrich, Ursula; Garbe, Claus; Kirchberger, Michael C; Eigentler, Thomas; Berking, Carola; Gesierich, Anja; Krackhardt, Angela M; Schadendorf, Dirk; Schuler, Gerold; Dummer, Reinhard; Heinzerling, Lucie M (2016). Neurological, respiratory, musculoskeletal, cardiac and ocular side-effects of anti-PD-1 therapy. European Journal of Cancer, 60:210-225.

Niessner, H; Schmitz, J; Tabatabai, G; et al; Dummer, Reinhard (2016). PI3K pathway inhibition achieves potent antitumor activity in melanoma brain metastases in vitro and in vivo. Clinical Cancer Research, 22(23):5818-5828.

Henning, Benjamin; Stieger, Pascale; Kamarachev, Jivko; Dummer, Reinhard; Goldinger, Simone M (2016). Pyogenic granuloma in patients treated with selective BRAF inhibitors: another manifestation of paradoxical pathway activation. Melanoma research, 26(3):304-7.

Claps, Giuseppina; Cheli, Yann; Zhang, Tongwu; Scortegagna, Marzia; Lau, Eric; Kim, Hyungsoo; Qi, Jianfei; Li, Jian-Liang; James, Brian; Dzung, Andreas; Levesque, Mitchell P; Dummer, Reinhard; Hayward, Nicholas K; Bosenberg, Marcus; Brown, Kevin M; Ronai, Ze'ev A (2016). A Transcriptionally Inactive ATF2 Variant Drives Melanomagenesis. Cell Reports, 15(9):1884-1892.

Rehefeldt-Erne, Susanne; Nägeli, Mirjam C; Winterton, Nina; Felderer, Lea; Weibel, Lisa; Hafner, Jürg; Dummer, Reinhard (2016). Nevoid Basal Cell Carcinoma Syndrome: Report from the Zurich Nevoid Basal Cell Carcinoma Syndrome Cohort. Dermatology, 232(3):285-292.

Goldinger, Simone M; Gobbi Bischof, Sharon; Fink-Puches, Regina; Klemke, Claus-Detlev; Dréno, Brigitte; Bagot, Martine; Dummer, Reinhard (2016). Efficacy and safety of Apo866 in patients with refractory or relapsed cutaneous t-cell lymphoma: a phase 2 clinical trial. JAMA Dermatology, 152(7):837-839.

Smith, Michael P; Brunton, Holly; Rowling, Emily J; Ferguson, Jennifer; Arozarena, Imanol; Miskolczi, Zsofia; Lee, Jessica L; Girotti, Maria R; Marais, Richard; Levesque, Mitchell P; Dummer, Reinhard; Frederick, Dennie T; Flaherty, Keith T; Cooper, Zachary A; Wargo, Jennifer A; Wellbrock, Claudia (2016). Inhibiting drivers of non-mutational drug tolerance is a salvage strategy for targeted melanoma therapy. Cancer Cell, 29(3):270-84.

Goldinger, Simone M; Stieger, Pascale; Meier, Barbara; Micaletto, Sara; Contassot, Emmanuel; French, Lars E; Dummer, Reinhard (2016). Cytotoxic cutaneous adverse drug reactions during anti-PD-1 therapy. Clinical Cancer Research, 22(16):4023-4029.

Amann, Valerie C; Dummer, Reinhard (2016). Localized hair repigmentation in a 91-year-old woman. JAMA Dermatology, 152(1):81-82.

Antsiferova, Maria; Piwko‐Czuchra, Aleksandra; Cangkrama, Michael; Wietecha, Mateusz; Sahin, Dilara; Birkner, Katharina; Amann, Valerie C; Levesque, Mitchell; Hohl, Daniel; Dummer, Reinhard; Werner, Sabine (2016). Activin promotes skin carcinogenesis by attraction and reprogramming of macrophages. EMBO Molecular Medicine:e201606493.

Diem, Stefan; Keller, Fabienne; Rüesch, Reinhard; Maillard, Samia A; Speiser, Daniel E; Dummer, Reinhard; Siano, Marco; Urner-Bloch, Ursula; Goldinger, Simone M; Flatz, Lukas (2016). Pembrolizumab-triggered uveitis: an additional surrogate marker for responders in melanoma immunotherapy? Journal of Immunotherapy, 39(9):379-382.

Rozati, Sima; Cheng, Phil F; Widmer, Daniel S; Fujii, Kazuyasu; Levesque, Mitchell Paul; Dummer, Reinhard (2016). Romidepsin and azacitidine synergize in their epigenetic modulatory effects to induce apoptosis in CTCL. Clinical Cancer Research, 22(8):2020-2031.

Ramelyte, Egle; Amann, Valerie C; Dummer, Reinhard (2016). Sonidegib for the treatment of advanced basal cell carcinoma. Expert Opinion on Pharmacotherapy, 17(14):1963-1968.

Deken, Marcel A; Gadiot, Jules; Jordanova, Ekaterina S; Lacroix, Ruben; van Gool, Melissa; Kroon, Paula; Pineda, Cristina; Geukes Foppen, Marnix H; Scolyer, Richard; Song, Ji-Ying; Verbrugge, Inge; Hoeller, Christoph; Dummer, Reinhard; Haanen, John B A G; Long, Georgina V; Blank, Christian U (2016). Targeting the MAPK and PI3K pathways in combination with PD1 blockade in melanoma. OncoImmunology, 5(12):e1238557.

Fan, Yiping; Lee, Seungjae; Wu, Gang; Easton, John; Yergeau, Donald; Dummer, Reinhard; Vogel, Peter; Kirkwood, John M; Barnhill, Raymond L; Pappo, Alberto; Bahrami, Armita (2016). Telomerase expression by aberrant methylation of the TERT promoter in melanoma arising in giant congenital nevi. Journal of Investigative Dermatology, 136(1):339-342.

Merlino, Glenn; Herlyn, Meenhard; Fisher, David E; Bastian, Boris C; Flaherty, Keith T; Davies, Michael A; Wargo, Jennifer A; Curiel-Lewandrowski, Clara; Weber, Michael J; Leachman, Sancy A; Soengas, Maria S; McMahon, Martin; Harbour, J. William; Swetter, Susan M; Aplin, Andrew E; Atkins, Michael B; Bosenberg, Marcus W; Dummer, Reinhard; Gershenwald, Jeffrey E; Halpern, Allan C; Herlyn, Dorothee; Karakousis, Giorgos C; Kirkwood, John M; Krauthammer, Michael; Lo, Roger S; Long, Georgina V; McArthur, Grant; Ribas, Antoni; Schuchter, Lynn; Sosman, Jeffrey A; Smalley, Keiran S; Steeg, Patricia; Thomas, Nancy E; Tsao, Hensin; Tueting, Thomas; Weeraratna, Ashani; Xu, George; Lomax, Randy; Martin, Alison; Silverstein, Steve; Turnham, Tim; Ronai, Ze'ev A (2016). The state of melanoma: challenges and opportunities. Pigment Cell & Melanoma Research, 29(4):404-416.

Dummer, Reinhard; Siano, Marco; Hunger, Robert E; Lindenblatt, Nicole; Braun, Ralph; Michielin, Oliver; Mihic-Probst, Daniela; von Moos, Roger; Najafi, Yousef; Guckenberger, Merlin; Arnold, Andreas (2016). The updated Swiss guidelines 2016 for the treatment and follow-up of cutaneous melanoma. Swiss Medical Weekly, 146:w14279.

Mangana, Joanna; Felderer, Lea; Cheng, Phil; French, Lars E; Dummer, Reinhard; Schad, Karin (2015). Diffuse cutaneous melanosis associated with malignant melanoma. Annals of dermatology, 27(6):780-781.

Del Prete, Valerio; Chaloupka, Karla; Holzmann, David; Fink, Daniel; Levesque, Mitchell; Dummer, Reinhard; Goldinger, Simone M (2015). Noncutaneous melanomas: a single-center analysis. Dermatology, 232(1):22-29.

Annese, Vito; Beaugerie, Laurent; Egan, Laurence; Biancone, Livia; Bolling, Claus; Brandts, Christian; Dierickx, Daan; Dummer, Reinhard; Fiorino, Gionata; Gornet, Jean Marc; Higgins, Peter; Katsanos, Konstantinos H; Nissen, Loes; Pellino, Gianluca; Rogler, Gerhard; Scaldaferri, Franco; Szymanska, Edyta; Eliakim, Rami (2015). European Evidence-based Consensus: Inflammatory Bowel Disease and Malignancies. Journal of Crohn's & colitis, 9(11):945-965.

Shain, A Hunter; Yeh, Iwei; Kovalyshyn, Ivanka; Sriharan, Aravindhan; Talevich, Eric; Gagnon, Alexander; Dummer, Reinhard; North, Jeffrey; Pincus, Laura; Ruben, Beth; Rickaby, William; D’Arrigo, Corrado; Robson, Alistair; Bastian, Boris C (2015). The Genetic Evolution of Melanoma from Precursor Lesions. New England Journal of Medicine, 373(20):1926-1936.

Levesque, Mitchell P; Dummer, Reinhard; Beerenwinkel, Niko (2015). Perturbing resistance: a network perspective. Pigment Cell & Melanoma Research, 29(1):5-7.

Grob, Jean Jacques; Amonkar, Mayur M; Karaszewska, Boguslawa; Schachter, Jacob; Dummer, Reinhard; Mackiewicz, Andrzej; Stroyakovskiy, Daniil; Drucis, Kamil; Grange, Florent; Chiarion-Sileni, Vanna; Rutkowski, Piotr; Lichinitser, Mikhail; Levchenko, Evgeny; Wolter, Pascal; Hauschild, Axel; Long, Georgina V; Nathan, Paul; Ribas, Antoni; Flaherty, Keith; Sun, Peng; Legos, Jeffrey J; McDowell, Diane Opatt; Mookerjee, Bijoyesh; Schadendorf, Dirk; Robert, Caroline (2015). Comparison of dabrafenib and trametinib combination therapy with vemurafenib monotherapy on health-related quality of life in patients with unresectable or metastatic cutaneous BRAF Val600-mutation-positive melanoma (COMBI-v): results of a phase 3, open-label, randomised trial. Lancet Oncology, 16(13):1389-1398.

Dummer, Reinhard; Schadendorf, Dirk; Ascierto, Paolo A; Larkin, James; Lebbé, Celeste; Hauschild, Axel (2015). Integrating first-line treatment options into clinical practice: what's new in advanced melanoma? Melanoma research, 25(6):461-469.

Van Allen, Eliezer M; Miao, Diana; Schilling, Bastian; Shukla, Sachet A; Blank, Christian; Zimmer, Lisa; Sucker, Antje; Hillen, Uwe; Geukes Foppen, Marnix H; Goldinger, Simone M; Utikal, Jochen; Hassel, Jessica C; Weide, Benjamin; Kaehler, Katharina C; Loquai, Carmen; Mohr, Peter; Gutzmer, Ralf; Dummer, Reinhard; Gabriel, Stacey; Wu, Catherine J; Schadendorf, Dirk; Garraway, Levi A (2015). Genomic correlates of response to CTLA4 blockade in metastatic melanoma. Science, 350(6257):207-211.

Kleffel, Sonja; Posch, Christian; Barthel, Steven R; Mueller, Hansgeorg; Schlapbach, Christoph; Guenova, Emmanuella; Elco, Christopher P; Lee, Nayoung; Juneja, Vikram R; Zhan, Qian; Lian, Christine G; Thomi, Rahel; Hoetzenecker, Wolfram; Cozzio, Antonio; Dummer, Reinhard; Mihm, Martin C; Flaherty, Keith T; Frank, Markus H; Murphy, George F; Sharpe, Arlene H; Kupper, Thomas S; Schatton, Tobias (2015). Melanoma cell-intrinsic PD-1 receptor functions promote tumor growth. Cell, 162(6):1242-1256.

Matsushita, Shigeto; Krähenbühl, Lukas; Otsuka, Atsushi; Mihic-Probst, Daniela; Cheng, Phil; Dummer, Reinhard; Goldinger, Simone M (2015). Histological evaluation of a "residual" metastasis after ipilimumab therapy in a patient with advanced melanoma. Journal of Dermatology, 42(9):927-928.

Freiberger, Sandra N; Cheng, Phil F; Iotzova-Weiss, Guergana; Neu, Johannes; Liu, Qinxiu; Dziunycz, Piotr; Zibert, John R; Dummer, Reinhard; Skak, Kresten; Levesque, Mitchell P; Hofbauer, Günther F L (2015). Ingenol mebutate signals via PKC/MEK/ERK in keratinocytes and induces interleukin decoy receptors IL1R2 and IL13RA2. Molecular Cancer Therapeutics, 14(9):2132-2142.

Widmer, Daniel S; Eichhoff, Ossia M; Dummer, Reinhard; Levesque, Mitchell P (2015). Melanoma's next top model, it is in the air. Experimental Dermatology, 24(9):659-660.

Ribas, Antoni; Puzanov, Igor; Dummer, Reinhard; Schadendorf, Dirk; Hamid, Omid; Robert, Caroline; Hodi, F Stephen; Schachter, Jacob; Pavlick, Anna C; Lewis, Karl D; Cranmer, Lee D; Blank, Christian U; O'Day, Steven J; Ascierto, Paolo A; Salama, April K S; Margolin, Kim A; Loquai, Carmen; Eigentler, Thomas K; Gangadhar, Tara C; Carlino, Matteo S; Agarwala, Sanjiv S; Moschos, Stergios J; Sosman, Jeffrey A; Goldinger, Simone M; Shapira-Frommer, Ronnie; Gonzalez, Rene; Kirkwood, John M; Wolchok, Jedd D; Eggermont, Alexander; Li, Xiaoyun Nicole; Zhou, Wei; Zernhelt, Adriane M; Lis, Joy; Ebbinghaus, Scot; Kang, S Peter; Daud, Adil (2015). Pembrolizumab versus investigator-choice chemotherapy for ipilimumab-refractory melanoma (KEYNOTE-002): a randomised, controlled, phase 2 trial. Lancet Oncology, 16(8):908-918.

Larkin, James; Chiarion-Sileni, Vanna; Gonzalez, Rene; Grob, Jean Jacques; Cowey, C Lance; Lao, Christopher D; Schadendorf, Dirk; Dummer, Reinhard; Smylie, Michael; Rutkowski, Piotr; Ferrucci, Pier F; Hill, Andrew; Wagstaff, John; Carlino, Matteo S; Haanen, John B; Maio, Michele; Marquez-Rodas, Ivan; McArthur, Grant A; Ascierto, Paolo A; Long, Georgina V; Callahan, Margaret K; Postow, Michael A; Grossmann, Kenneth; Sznol, Mario; Dreno, Brigitte; Bastholt, Lars; Yang, Arvin; Rollin, Linda M; Horak, Christine; Hodi, F Stephen; Wolchok, Jedd D (2015). Combined Nivolumab and Ipilimumab or monotherapy in untreated melanoma. New England Journal of Medicine, 373(1):23-34.

Kim, Hyungsoo; Frederick, Dennie T; Levesque, Mitchell P; Cooper, Zachary A; Feng, Yongmei; Krepler, Clemens; Brill, Laurence; Samuels, Yardena; Hayward, Nicholas K; Perlina, Ally; Piris, Adriano; Zhang, Tongwu; Halaban, Ruth; Herlyn, Meenhard M; Brown, Kevin M; Wargo, Jennifer A; Dummer, Reinhard; Flaherty, Keith T; Ronai, Ze'ev A (2015). Downregulation of the ubiquitin ligase RNF125 underlies resistance of melanoma cells to BRAF inhibitors via JAK1 deregulation. Cell Reports, 11(9):1458-1473.

Migden, Michael R; Guminski, Alexander; Gutzmer, Ralf; Dirix, Luc; Lewis, Karl D; Combemale, Patrick; Herd, Robert M; Kudchadkar, Ragini; Trefzer, Uwe; Gogov, Sven; Pallaud, Celine; Yi, Tingting; Mone, Manisha; Kaatz, Martin; Loquai, Carmen; Stratigos, Alexander J; Schulze, Hans-Joachim; Plummer, Ruth; Chang, Anne Lynn S; Cornélis, Frank; Lear, John T; Sellami, Dalila; Dummer, Reinhard (2015). Treatment with two different doses of sonidegib in patients with locally advanced or metastatic basal cell carcinoma (BOLT): a multicentre, randomised, double-blind phase 2 trial. Lancet Oncology, 16(6):716-728.

Basset-Seguin, Nicole; Hauschild, Axel; Grob, Jean-Jacques; Kunstfeld, Rainer; Dréno, Brigitte; Mortier, Laurent; Ascierto, Paolo A; Licitra, Lisa; Dutriaux, Caroline; Thomas, Luc; Jouary, Thomas; Meyer, Nicolas; Guillot, Bernard; Dummer, Reinhard; Fife, Kate; Ernst, D Scott; Williams, Sarah; Fittipaldo, Alberto; Xynos, Ioannis; Hansson, Johan (2015). Vismodegib in patients with advanced basal cell carcinoma (STEVIE): a pre-planned interim analysis of an international, open-label trial. Lancet Oncology, 16(6):729-736.

Eggermont, Alexander M M; Chiarion-Sileni, Vanna; Grob, Jean-Jacques; Dummer, Reinhard; Wolchok, Jedd D; Schmidt, Henrik; Hamid, Omid; Robert, Caroline; Ascierto, Paolo A; Richards, Jon M; Lebbé, Céleste; Ferraresi, Virginia; Smylie, Michael; Weber, Jeffrey S; Maio, Michele; Konto, Cyril; Hoos, Axel; de Pril, Veerle; Gurunath, Ravichandra Karra; de Schaetzen, Gaetan; Suciu, Stefan; Testori, Alessandro (2015). Adjuvant ipilimumab versus placebo after complete resection of high-risk stage III melanoma (EORTC 18071): a randomised, double-blind, phase 3 trial. Lancet Oncology, 16(5):522-530.

Otsuka, Atsushi; Levesque, Mitchell P; Dummer, Reinhard; Kabashima, Kenji (2015). Hedgehog signaling in basal cell carcinoma. Journal of Dermatological Science, 78(2):95-100.

Surace, Laura; Lysenko, Veronika; Fontana, Andrea Orlando; Cecconi, Virginia; Janssen, Hans; Bicvic, Antonela; Okoniewski, Michal; Pruschy, Martin; Dummer, Reinhard; Neefjes, Jacques; Knuth, Alexander; Gupta, Anurag; van den Broek, Maries (2015). Complement is a central mediator of radiotherapy-induced tumor-specific immunity and clinical response. Immunity, 42(4):767-777.

Galliker, Nadja A; Murer, Carla; Kamarashev, Jivko; Dummer, Reinhard; Goldinger, Simone M (2015). Clinical observation of panniculitis in two patients with BRAF-mutated metastatic melanoma treated with a combination of a BRAF inhibitor and a MEK inhibitor. European Journal of Dermatology, 25(2):177-180.

Schoenewolf, Nicola L; Hafner, Jürg; Dummer, Reinhard; Bogdan Allemann, Inja (2015). Laser treatment of solar lentigines on dorsum of hands: QS Ruby laser versus ablative CO2 fractional laser - a randomized controlled trial. European Journal of Dermatology, 25(2):122-126.

Raaijmakers, Marieke I G; Widmer, Daniel S; Maudrich, Melanie; Koch, Tabea; Langer, Alice; Flace, Anna; Schnyder, Claudia; Dummer, Reinhard; Levesque, Mitchell P (2015). A new live cell biobank workflow efficiently recovers heterogeneous melanoma cells from native biopsies. Experimental Dermatology, 24(5):377-380.

Goldinger, Simone M; Rinderknecht, Jeannine; Dummer, Reinhard; Kuhn, Felix Pierre; Yang, Kuo-Hsiung; Lee, Lucy; Ayala, Ruben C; Racha, Jagdish; Geng, Wanping; Moore, David; Liu, Mei; Joe, Andrew K; Bazan, Selby Patricia Gil; Grippo, Joseph F (2015). A single-dose mass balance and metabolite-profiling study of vemurafenib in patients with metastatic melanoma. Pharmacology Research & Perspectives, 3(2):e00113.

Dummer, Reinhard; Goldinger, Simone M; Paulitschke, Verena; Levesque, Mitchell P (2015). Curing advanced melanoma by 2025. Current Opinion in Oncology, 27(2):125-127.

DeSimone, Jennifer A; Sodha, Pooja; Ignatova, Desislava; Dummer, Reinhard; Cozzio, Antonio; Guenova, Emmanuella (2015). Recent advances in primary cutaneous T-cell lymphoma. Current Opinion in Oncology, 27(2):128-133.

Tackenberg, Selma; Gehrig, Anita; Dummer, Reinhard; Navarini, Alexander A (2015). External beam radiotherapy of extramammary Paget disease. Cutis; cutaneous medicine for the practitioner, 95(2):109-112.

Urosevic-Maiwald, Mirjana; Barysch, Marjam J; Cheng, Phil F; Karpova, Maria B; Steinert, Hans; Okoniewski, Michal J; Dummer, Reinhard (2015). In vivo profiling reveals immunomodulatory effects of sorafenib and dacarbazine on melanoma. OncoImmunology, 4(2):e988458.

Shakhova, Olga; Cheng, Phil; Mishra, Pravin J; Zingg, Daniel; Schaefer, Simon M; Debbache, Julien; Häusel, Jessica; Matter, Claudia; Guo, Theresa; Davis, Sean; Meltzer, Paul; Mihic-Probst, Daniela; Moch, Holger; Wegner, Michael; Merlino, Glenn; Levesque, Mitchell P; Dummer, Reinhard; Santoro, Raffaella; Cinelli, Paolo; Sommer, Lukas (2015). Antagonistic cross-regulation between Sox9 and Sox10 controls an anti-tumorigenic program in melanoma. PLoS Genetics, 11(1):e1004877.

Zingg, Daniel; Debbache, Julien; Schaefer, Simon M; Tuncer, Eylul; Frommel, Sandra C; Cheng, Phil; Arenas-Ramirez, Natalia; Haeusel, Jessica; Zhang, Yudong; Bonalli, Mario; McCabe, Michael T; Creasy, Caretha L; Levesque, Mitchell P; Boyman, Onur; Santoro, Raffaella; Shakhova, Olga; Dummer, Reinhard; Sommer, Lukas (2015). The epigenetic modifier EZH2 controls melanoma growth and metastasis through silencing of distinct tumour suppressors. Nature Communications, 6:6051.

Otsuka, Atsushi; Dreier, Jil; Cheng, Phil F; Nägeli, Mirjam; Lehmann, Holger; Felderer, Lea; Frew, Ian J; Matsushita, Shigeto; Levesque, Mitchell P; Dummer, Reinhard (2015). Hedgehog Pathway Inhibitors Promote Adaptive Immune Responses in Basal Cell Carcinoma. Clinical Cancer Research:1289-1297.

Mehra, Tarun; Ikenberg, Kristian; Moos, Rudolf Maria; Benz, Rudolf; Nair, Gayathri; Schanz, Urs; Haralambieva, Eugenia; Hoetzenecker, Wolfram; Dummer, Reinhard; French, Lars Einar; Guenova, Emmanuella; Cozzio, Antonio (2015). Brentuximab as a treatment for CD30+ Mycosis Fungoides and Sézary Syndrome. JAMA Dermatology, 151(1):73-77.

Robert, Caroline; Karaszewska, Boguslawa; Schachter, Jacob; Rutkowski, Piotr; Mackiewicz, Andrzej; Stroiakovski, Daniil; Lichinitser, Michael; Dummer, Reinhard; Grange, Florent; Mortier, Laurent; Chiarion-Sileni, Vanna; Drucis, Kamil; Krajsova, Ivana; Hauschild, Axel; Lorigan, Paul; Wolter, Pascal; Long, Georgina V; Flaherty, Keith; Nathan, Paul; Ribas, Antoni; Martin, Anne-Marie; Sun, Peng; Crist, Wendy; Legos, Jeff; Rubin, Stephen D; Little, Shonda M; Schadendorf, Dirk (2015). Improved overall survival in melanoma with combined dabrafenib and trametinib. New England Journal of Medicine, 372(1):30-39.

Lorigan, Paul; Ascierto, Paolo A; Dummer, Reinhard; Eggermont, Alexander M; Flaherty, Keith T; Garbe, Claus; Gogas, Helen; Hauschild, Axel; Kefford, Richard F; Kirkwood, John M; Larkin, James; Long, Georgina V; Maio, Michele; McArthur, Grant A; Ribas, Antoni; Robert, Caroline; Schadendorf, Dirk; Sondak, Vernon K; Wolchok, Jedd D; Hudson, Andrew M (2015). Expanded access programmes: patient interests versus clinical trial integrity. Lancet Oncology, 16(1):15-17.

Schlegel, Natalie C; von Planta, Anina; Widmer, Daniel S; Dummer, Reinhard; Christofori, Gerhard (2015). PI3K signalling is required for a TGFβ-induced epithelial-mesenchymal-like transition (EMT-like) in human melanoma cells. Experimental Dermatology, 24(1):22-28.

Sullivan, Ryan; LoRusso, Patricia; Boerner, Scott; Dummer, Reinhard (2015). Achievements and challenges of molecular targeted therapy in melanoma. Educational Book:177-186.

Amann, Valerie C; Dummer, Reinhard (2015). Aktuelle Systemtherapien bei fortgeschrittenem Melanom Neue Medikamente – neue Kombinationen. Schweizer Zeitschrift für Onkologie, 5:2-5.

Mangana, Joanna; Cheng, Phil F; Schindler, Katja; Weide, Benjamin; Held, Ulrike; Frauchiger, Anna L; Romano, Emanuella; Kähler, Katharina C; Rozati, Sima; Rechsteiner, Markus; Moch, Holger; Michielin, Olivier; Garbe, Claus; Hauschild, Axel; Hoeller, Christoph; Dummer, Reinhard; Goldinger, Simone M (2015). Analysis of BRAF and NRAS mutation status in advanced melanoma patients treated with anti-CTLA-4 antibodies: association with overall survival? PLoS ONE, 10(10):e0139438.

Cheng, Phil F; Dummer, Reinhard; Levesque, Mitchell P (2015). Data mining the cancer genome atlas in the era of precision cancer medicine. Swiss Medical Weekly, 145:w14183.

Amann, Valerie C; Dreier, Jil; Ignatova, Desislava; Kamarashev, Jivko; Kerl, Katrin; Kempf, Werner; Pascolo, Steve; Dummer, Reinhard; Cozzio, Antonio; Guenova, Emmanuella (2015). Disseminated Primary Cutaneous CD8+ Small/medium-sized Pleomorphic T-cell Lymphoma Responding to Hydroxychloroquine. Acta Dermato-Venereologica, 95(5):602-603.

Ascierto, Paolo A; Atkins, Michael; Bifulco, Carlo; Botti, Gerardo; Cochran, Alistair; Davies, Michael; Demaria, Sandra; Dummer, Reinhard; Ferrone, Soldano; Formenti, Silvia; Gajewski, Thomas F; Garbe, Claus; Khleif, Samir; Kiessling, Rolf; Lo, Roger; Lorigan, Paul; Arthur, Grant Mc; Masucci, Giuseppe; Melero, Ignacio; Mihm, Martin; Palmieri, Giuseppe; Parmiani, Giorgio; Puzanov, Igor; Romero, Pedro; Schilling, Bastian; Seliger, Barbara; Stroncek, David; Taube, Janis; Tomei, Sara; Zarour, Hassane M; Testori, Alessandro; Wang, Ena; Galon, Jérôme; Ciliberto, Gennaro; Mozzillo, Nicola; Marincola, Francesco M; Thurin, Magdalena (2015). Future perspectives in melanoma research: meeting report from the “Melanoma Bridge”: Napoli, December 3rd–6th 2014. Journal of Translational Medicine, 13(1):online.

Steinert, Hans; Dreier, Jil; Dummer, Reinhard; Schäfer, Niklaus (2015). Melanoma. In: von Schulthess, Gustav K. Molecular Anatomic Imaging. Hagerstown, MD 21740: Wolters Kluwer Health, 537-547.

Cheng, Phil F; Shakhova, Olga; Widmer, Daniel S; Eichhoff, Ossia M; Zingg, Daniel; Frommel, Sandra C; Belloni, Benedetta; Raaijmakers, Marieke Ig; Goldinger, Simone M; Santoro, Raffaella; Hemmi, Silvio; Sommer, Lukas; Dummer, Reinhard; Levesque, Mitchell P (2015). Methylation-dependent SOX9 expression mediates invasion in human melanoma cells and is a negative prognostic factor in advanced melanoma. Genome Biology, 16:42.

Lee, Seungjae; Barnhill, Raymond L; Dummer, Reinhard; Dalton, James; Wu, Jianrong; Pappo, Alberto; Bahrami, Armita (2015). TERT promoter mutations are predictive of aggressive clinical behavior in patients with spitzoid melanocytic neoplasms. Scientific Reports, 5:11200.

Espinosa, Enrique; Grob, Jean-Jacques; Dummer, Reinhard; Rutkowski, Piotr; Robert, Caroline; Gogas, Helen; Kefford, Richard; Eggermont, Alexander M M; Martin Algarra, Salvador; Hauschild, Axel; Schadendorf, Dirk (2015). Treatment Algorithms in Stage IV Melanoma. American Journal of Therapeutics, 22(1):61-67.

Rozati, Sima; Kempf, Werner; Ostheeren-Michaelis, Sonja; Bode-Lesniewska, Beata; Zimmermann, Dieter R; Dummer, Reinhard; Cozzio, Antonio (2014). Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type, With Bilateral Intraocular Involvement and Infiltration to the CNS. Journal of Clinical Oncology:1-4.

Dreier, Jil; Dummer, Reinhard; Felderer, Lea; Nägeli, Mirjam; Gobbi, Sharon; Kunstfeld, Rainer (2014). Emerging drugs and combination strategies for basal cell carcinoma. Expert opinion on emerging drugs, 19(3):353-365.

Kempf, Werner; Kazakov, Dmitry V; Rütten, Arno; Rupec, Rudolf A; Talarcik, Petr; Ballová, Veronika; Kerl, Katrin; Dummer, Reinhard; Lautenschlager, Stephan; Zimmermann, Dieter R; Tinguely, Marianne (2014). Primary cutaneous follicle center lymphoma with diffuse CD30 expression: a report of 4 cases of a rare variant. Journal of the American Academy of Dermatology, 71(3):548-54.

Scholz, Matthias; Buder, Susanne; Kerl, Katrin; Dummer, Reinhard; Garbe, Claus (2014). New diagnostic method for lesions with transepidermal melanocytic migration. JAMA Dermatology, 150(6):654-656.

Dummer, Reinhard; Goldinger, Simone M; Widmer, Daniel; Dreier, Jil; Levesque, Mitchell P (2014). To B-(RAF) or not to be. Journal of Investigative Dermatology, 134(5):1200-1201.

Rodon, Jordi; Tawbi, Hussein A; Thomas, Anne L; Stoller, Ronald; Turtschi, Christian P; Baselga, Jose; Sarantopoulos, John; Mahalingam, Devalingam; Shou, Yaping; Moles, Melissa A; Yang, Lin; Granvil, Camille; Hurh, Eunju; Rose, Kristine L; Amakye, Dereck D; Dummer, Reinhard; Mita, Alain C (2014). A Phase 1, Multicenter, Open-Label, First-in-Human, Dose-Escalation Study of the Oral Hedgehog Inhibitor Sonidegib (LDE225) in Patients With Advanced Solid Tumors. Clinical Cancer Research, 20(7):1900-1909.

Lenggenhager, Daniela; Curioni-Fontecedro, Alessandra; Storz, Martina; Shakhova, Olga; Sommer, Lukas; Widmer, Daniel S; Seifert, Burkhardt; Moch, Holger; Dummer, Reinhard; Mihic-Probst, Daniela (2014). An aggressive hypoxia related subpopulation of melanoma cells is TRP-2 Negative. Translational Oncology, 7(2):206-212.

Schoenewolf, Nicola L; Belloni, Benedetta; Simcock, Mathew; Tonolla, Sabina; Vogt, Pascale; Scherrer, Ellen; Holzmann, David; Dummer, Reinhard (2014). Clinical implications of distinct metastasizing preferences of different melanoma subtypes. European Journal of Dermatology, 24(2):236-241.

Barysch, Marjam J; Levesque, Mitchell P; Cheng, Phil; Karpova, Maria B; Mihic-Probst, Daniela; Civenni, Gianluca; Shakhova, Olga; Sommer, Lukas; Biedermann, Thomas; Schiestl, Clemens; Dummer, Reinhard (2014). Coexpression of SOX10/CD271 (p75(NTR)) and β-Galactosidase in large to giant congenital melanocytic nevi of pediatric patients. Dermatopathology, 1(1):35-46.

Barysch, Marjam J; Levesque, Mitchell P; Cheng, Phil; Karpova, Maria B; Mihic-Probst, Daniela; Civenni, Gianluca; Shakhova, Olga; Sommer, Lukas; Biedermann, Thomas; Schiestl, Clemens; Dummer, Reinhard (2014). Coexpression of SOX10/CD271 (p75NTR) and beta-galactosidase in large to giant congenital melanocytic nevi of pediatric patients. Dermatopathology, 1(1):35-46.

Imhof, Laurence; Dummer, Reinhard (2014). Iatrogene Tätowierung nach Eiseninfusion. Swiss Medical Forum, 14(40):750-751.

McCusker, Margaret; Basset-Seguin, Nicole; Dummer, Reinhard; Lewis, Karl; Schadendorf, Dirk; Sekulic, Aleksandar; Hou, Jeannie; Wang, Lisa; Yue, Huibin; Hauschild, Axel (2014). Metastatic basal cell carcinoma: Prognosis dependent on anatomic site and spread of disease. European Journal of Cancer, 50(4):774-783.

Gehrke, Samuel; Otsuka, Atsushi; Huber, Roman; Meier, Barbara; Kistowska, Magdalena; Fenini, Gabriele; Cheng, Phil; Dummer, Reinhard; Kerl, Katrin; Contassot, Emmanuel; French, Lars E (2014). Metastatic melanoma cell lines do not secrete IL-1β but promote IL-1β production from macrophages. Journal of Dermatological Science, 74(2):167-169.

Guenova, Emmanuella; Hoetzenecker, Wolfram; Rozati, Sima; Levesque, Mitchell P; Dummer, Reinhard; Cozzio, Antonio (2014). Novel therapies for cutaneous T-cell lymphoma: what does the future hold? Expert Opinion on Investigational Drugs, 23(4):457-467.

Dummer, Reinhard (2014). Precision medicine and skin cancer therapy: dealing with a moving target. Current Opinion in Oncology, 26(2):182-183.

Mehra, Tarun; Grözinger, Gerd; Mann, Steven; Guenova, Emmanuella; Moos, Rudolf; Röcken, Martin; Claussen, Claus Detlef; Dummer, Reinhard; Clasen, Stephan; Naumann, Aline; Garbe, Claus (2014). Primary localization and tumor thickness as prognostic factors of survival in patients with mucosal melanoma. PLoS ONE, 9(11):e112535.

McArthur, Grant A; Chapman, Paul B; Robert, Caroline; Larkin, James; Haanen, John B; Dummer, Reinhard; Ribas, Antoni; Hogg, David; Hamid, Omid; Ascierto, Paolo A; Garbe, Claus; Testori, Alessandro; Maio, Michele; Lorigan, Paul; Lebbé, Celeste; Jouary, Thomas; Schadendorf, Dirk; O'Day, Stephen J; Kirkwood, John M; Eggermont, Alexander M; Dréno, Brigitte; Sosman, Jeffrey A; Flaherty, Keith T; Yin, Ming; Caro, Ivor; Cheng, Suzanne; Trunzer, Kerstin; Hauschild, Axel (2014). Safety and efficacy of vemurafenib in BRAF(V600E) and BRAF(V600K) mutation-positive melanoma (BRIM-3): extended follow-up of a phase 3, randomised, open-label study. Lancet Oncology, 15(3):323-332.

Flaherty, Keith T; Hennig, Michael; Lee, Sandra J; Ascierto, Paolo A; Dummer, Reinhard; Eggermont, Alexander M M; Hauschild, Axel; Kefford, Richard; Kirkwood, John M; Long, Georgina V; Lorigan, Paul; Mackensen, Andreas; McArthur, Grant; O'Day, Steven; Patel, Poulam M; Robert, Caroline; Schadendorf, Dirk (2014). Surrogate endpoints for overall survival in metastatic melanoma: a meta-analysis of randomised controlled trials. Lancet Oncology, 15(3):297-304.

Dreno, Brigitte; Urosevic-Maiwald, Mirjana; Kim, Youn; Guitart, Joan; Duvic, Madeleine; Dereure, Olivier; Khammari, Amir; Knol, Anne-Chantal; Derbij, Anna; Lusky, Monika; Didillon, Isabelle; Santoni, Anne-Marie; Acres, Bruce; Bataille, Vincent; Chenard, Marie-Pierre; Bleuzen, Pascal; Limacher, Jean-Marc; Dummer, Reinhard (2014). TG1042 (Adenovirus-interferon-γ) in primary cutaneous B-cell lymphomas: A phase II clinical trial. PLoS ONE, 9(2):e83670.

Goldinger, Simone M; Zimmer, Lisa; Schulz, Carsten; Ugurel, Selma; Hoeller, Christoph; Kaehler, Katharina C; Schadendorf, Dirk; Hassel, Jessica C; Becker, Juergen; Hauschild, Axel; Dummer, Reinhard (2014). Upstream mitogen-activated protein kinase (MAPK) pathway inhibition: MEK inhibitor followed by a BRAF inhibitor in advanced melanoma patients. European Journal of Cancer, 50(2):406-410.

Dummer, Reinhard; Goldinger, Simone M; Turtschi, Christian P; Eggmann, Nina B; Michielin, Olivier; Mitchell, Lada; Veronese, Luisa; Hilfiker, Paul René; Felderer, Lea; Rinderknecht, Jeannine D (2014). Vemurafenib in patients with BRAF(V600) mutation-positive melanoma with symptomatic brain metastases: Final results of an open-label pilot study. European Journal of Cancer, 50(3):611-621.

Walter, Anne; Schäfer, Matthias; Cecconi, Virginia; Matter, Claudia; Urosevic-Maiwald, Mirjana; Belloni, Benedetta; Schönewolf, Nicola; Dummer, Reinhard; Bloch, Wilhelm; Werner, Sabine; Beer, Hans-Dietmar; Knuth, Alexander; van den Broek, Maries (2013). Aldara activates TLR7-independent immune defence. Nature Communications, 4:1560.

Dreier, Jil; Felderer, Lea; Barysch, Marjam; Rozati, Sima; Dummer, Reinhard (2013). Basal cell carcinoma: a paradigm for targeted therapies. Expert Opinion on Pharmacotherapy, 14(10):1307-1318.

Stadler, Rudolf; Assaf, Chalid; Klemke, Claus-Detlev; Nashan, Dorothee; Weichenthal, Michael; Dummer, Reinhard; Sterry, Wolfram (2013). Brief S2k guidelines - Cutaneous lymphomas. JDDG - Journal der Deutschen Dermatologischen Gesellschaft, 11 Suppl:19-28, 20.

Barysch, Marjam J; Weibel, Lisa; Neuhaus, Kathrin; Subotic, Ulrike; Schärer, Leo; Donghi, Davide; Hafner, Juerg; Braun, Ralph; Läuchli, Severin; Dummer, Reinhard; Schiestl, Clemens (2013). Dermatofibrosarcoma protuberans in childhood treated with slow Mohs micrographic surgery. Pediatric Dermatology, 30(4):462-468.

Rolfs, Frank; Huber, Marcel; Gruber, Florian; Böhm, Friederike; Pfister, Herbert J; Bochkov, Valery N; Tschachler, Erwin; Dummer, Reinhard; Hohl, Daniel; Schäfer, Matthias; Werner, Sabine (2013). Dual role of the antioxidant enzyme peroxiredoxin 6 in skin carcinogenesis. Cancer Research, 73(11):3460-3469.

Widmer, Daniel S; Hoek, Keith S; Cheng, Phil F; Eichhoff, Ossia M; Biedermann, Thomas; Raaijmakers, Marieke I G; Hemmi, Silvio; Dummer, Reinhard; Levesque, Mitchell P (2013). Hypoxia contributes to melanoma heterogeneity by triggering HIF1α-dependent phenotype switching. Journal of Investigative Dermatology, 133(10):2436-2443.

Dummer, Reinhard; Rozati, Sima; Guenova, Emmanuella; Cozzio, Antonio (2013). Less can be more: the impact of chemotherapy on cutaneous T-cell lymphomas. Future Oncology (London, England), 9(8):1061-1064.

Accart, Nathalie; Urosevic-Maiwald, Mirjana; Dummer, Reinhard; Bataille, Vincent; Kehrer, Nadine; Niculescu, Cristina; Limacher, Jean-Marc; Chenard, Marie-Pierre; Bonnefoy, Jean-Yves; Rooke, Ronald (2013). Lymphocytic infiltration in the cutaneous lymphoma microenvironment after injection of TG1042. Journal of Translational Medicine, 11:226.

Ascierto, Paolo A; Schadendorf, Dirk; Berking, Carola; Agarwala, Sanjiv S; van Herpen, Carla Ml; Queirolo, Paola; Blank, Christian U; Hauschild, Axel; Beck, J Thaddeus; St-Pierre, Annie; Niazi, Faiz; Wandel, Simon; Peters, Malte; Zubel, Angela; Dummer, Reinhard (2013). MEK162 for patients with advanced melanoma harbouring NRAS or Val600 BRAF mutations: a non-randomised, open-label phase 2 study. Lancet Oncology, 14(3):249-256.

Raaijmakers, Marieke I G; Rozati, Sima; Goldinger, Simone M; Widmer, Daniel S; Dummer, Reinhard; Levesque, Mitchell P (2013). Melanoma immunotherapy: historical precedents, recent successes and future prospects. Immunotherapy, 5(2):169-182.

Das Thakur, Meghna; Salangsang, Fernando; Landman, Allison S; Sellers, William R; Pryer, Nancy K; Levesque, Mitchell P; Dummer, Reinhard; McMahon, Martin; Stuart, Darrin D (2013). Modelling vemurafenib resistance in melanoma reveals a strategy to forestall drug resistance. Nature, 494(7436):251-255.

Kolios, Antonios G A; Marques Maggio, Ewerton; Gubler, Christoph; Cozzio, Antonio; Dummer, Reinhard; French, Lars E; Navarini, Alexander A (2013). Oral, esophageal and cutaneous lichen ruber planus controlled with alitretinoin: case report and review of the literature. Dermatology, 226(4):302-310.

Duvic, Madeleine; Dummer, Reinhard; Becker, Jürgen C; Poulalhon, Nicolas; Ortiz Romero, Pablo; Grazia Bernengo, Maria; Lebbé, Celeste; Assaf, Chalid; Squier, Margaret; Williams, Denise; Marshood, Miriam; Tai, Feng; Prince, H Miles (2013). Panobinostat activity in both bexarotene-exposed and -naïve patients with refractory cutaneous T-cell lymphoma: Results of a phase II trial. European Journal of Cancer, 49(2):386-394.

Weber, Jeffrey S; Dummer, Reinhard; de Pril, Veerle; Lebbé, Celeste; Hodi, F Stephen (2013). Patterns of onset and resolution of immune-related adverse events of special interest with ipilimumab: detailed safety analysis from a phase 3 trial in patients with advanced melanoma. Cancer, 119(9):1675-1682.

Feldmeyer, Laurence; Shojaati, Golnar; Spanaus, Katharina-Susanne; Navarini, Alexander; Theler, Barbara; Donghi, Davide; Urosevic-Maiwald, Mirjana; Glatz, Martin; Imhof, Laurence; Barysch, Marjam J; Dummer, Reinhard; Roos, Malgorzata; French, Lars E; Surber, Christian; Hofbauer, Günther F L (2013). Phototherapy with UVB narrowband, UVA/UVBnb, and UVA1 differentially impacts serum 25-hydroxyvitamin-D3. Journal of the American Academy of Dermatology, 69(4):530-536.

Rinderknecht, Jeannine D; Goldinger, Simone M; Rozati, Sima; Kamarashev, Jivko; Kerl, Katrin; French, Lars E; Dummer, Reinhard; Belloni, Benedetta (2013). RASopathic skin eruptions during vemurafenib therapy. PLoS ONE, 8(3):e58721.

Rozati, Sima; Naef, Lukas; Levesque, Mitchell P; French, Lars E; Dummer, Reinhard (2013). Real-life experience with pegylated interferon and conventional interferon in adjuvant melanoma therapy. Journal of Immunotherapy, 36(1):52-56.

Cronin, Julia C; Watkins-Chow, Dawn E; Incao, Art; Hasskamp, Joanne H; Schönewolf, Nicola; Aoude, Lauren G; Hayward, Nicholas K; Bastian, Boris C; Dummer, Reinhard; Loftus, Stacie K; Pavan, William J (2013). SOX10 ablation arrests cell cycle, induces senescence, and suppresses melanomagenesis. Cancer Research, 73(18):5709-5718.

Robert, Caroline; Dummer, Reinhard; Gutzmer, Ralf; Lorigan, Paul; Kim, Kevin B; Nyakas, Marta; Arance, Ana; Liszkay, Gabriella; Schadendorf, Dirk; Cantarini, Mireille; Spencer, Stuart; Middleton, Mark R (2013). Selumetinib plus dacarbazine versus placebo plus dacarbazine as first-line treatment for BRAF-mutant metastatic melanoma: a phase 2 double-blind randomised study. Lancet Oncology, 14(8):733-740.

Franzen, Daniel; Schad, Karin; Dummer, Reinhard; Russi, Erich W (2013). Severe acute respiratory distress syndrome due to ipilimumab. European Respiratory Journal, 42(3):866-868.

Rozati, Sima; Kerl, Katrin; Kempf, Werner; Tinguely, Marianne; Zimmermann, Dieter R; Dummer, Reinhard; Cozzio, Antonio (2013). Spindle-cell variant of primary cutaneous follicle center lymphoma spreading to the hepatobiliary tree, mimicking Klatskin tumor. Journal of Cutaneous Pathology, 40(1):56-60.

Niessner, Heike; Forschner, Andrea; Klumpp, Bernhard; Honegger, Jürgen B; Witte, Maria; Bornemann, Antje; Dummer, Reinhard; Adam, Annemarie; Bauer, Jürgen; Tabatabai, Ghazaleh; Flaherty, Keith; Sinnberg, Tobias; Beck, Daniela; Leiter, Ulrike; Mauch, Cornelia; Roesch, Alexander; Weide, Benjamin; Eigentler, Thomas; Schadendorf, Dirk; Garbe, Claus; Kulms, Dagmar; Quintanilla-Martinez, Leticia; Meier, Friedegund (2013). Targeting hyperactivation of the AKT survival pathway to overcome therapy resistance of melanoma brain metastases. Cancer Medicine, 2(1):76-85.

Voskens, Caroline J; Goldinger, Simone M; Loquai, Carmen; Robert, Caroline; Kaehler, Katharina C; Berking, Carola; Bergmann, Tanja; Bockmeyer, Clemens L; Eigentler, Thomas; Fluck, Michael; Garbe, Claus; Gutzmer, Ralf; Grabbe, Stephan; Hauschild, Axel; Hein, Rüdiger; Hundorfean, Gheorghe; Justich, Armin; Keller, Ullrich; Klein, Christina; Mateus, Christine; Mohr, Peter; Paetzold, Sylvie; Satzger, Imke; Schadendorf, Dirk; Schlaeppi, Marc; Schuler, Gerold; Schuler-Thurner, Beatrice; Trefzer, Uwe; Ulrich, Jens; Vaubel, Julia; von Moos, Roger; Weder, Patrik; Wilhelm, Tabea; Göppner, Daniela; Dummer, Reinhard; Heinzerling, Lucie M (2013). The price of tumor control: an analysis of rare side effects of anti-CTLA-4 therapy in metastatic melanoma from the ipilimumab network. PLoS ONE, 8(1):e53745.

Dummer, Reinhard (2013). Treating basal-cell carcinoma in a real life setting. Lancet Oncology, 14(7):572-573.

Belloni, Benedetta; Lambertini, Chiara; Nuciforo, Paolo; Phillips, Jay; Bruening, Eric; Wong, Stephane; Dummer, Reinhard (2013). Will PAXgene substitute formalin? A morphological and molecular comparative study using a new fixative system. Journal of Clinical Pathology, 66(2):124-135.

Zimmer, Lisa; Hillen, Uwe; Livingstone, Elisabeth; Lacouture, Mario E; Busam, Klaus; Carvajal, Richard D; Egberts, Friederike; Hauschild, Axel; Kashani-Sabet, Mohammed; Goldinger, Simone M; Dummer, Reinhard; Long, Georgina V; McArthur, Grant; Scherag, André; Sucker, Antje; Schadendorf, Dirk (2012). Atypical Melanocytic Proliferations and New Primary Melanomas in Patients With Advanced Melanoma Undergoing Selective BRAF Inhibition. Journal of Clinical Oncology, 30(19):2375-2383.

Belloni, Benedetta; Schönewolf, Nicola; Rozati, Sima; Goldinger, Simone M; Dummer, Reinhard (2012). Cutaneous drug eruptions associated with the use of new oncological drugs. Chemical Immunology and Allergy, 97:191-202.

Schoenewolf, Nicola L; Dummer, Reinhard; Mihic-Probst, Daniela; Moch, Holger; Simcock, Mathew; Ochsenbein, Adrian; Gillessen, Silke; Schraml, Peter; von Moos, Roger (2012). Detecting BRAF mutations in formalin-fixed melanoma: experiences with two state-of-the-art techniques. Case Reports in Oncology, 5(2):280-289.

Eggermont, Alexander M M; Suciu, Stefan; Testori, Alessandro; Santinami, Mario; Kruit, Wim H J; Marsden, Jeremy; Punt, Cornelis J A; Salès, François; Dummer, Reinhard; Robert, Caroline; Schadendorf, Dirk; Patel, Poulam M; de Schaetzen, Gaetan; Spatz, Alan; Keilholz, Ulrich (2012). Long-term results of the randomized phase III trial EORTC 18991 of adjuvant therapy with pegylated interferon alfa-2b versus observation in resected stage III melanoma. Journal of Clinical Oncology, 30(31):3810-3818.

Goldinger, Simone M; Dummer, Reinhard; Baumgaertner, Petra; Mihic-Probst, Daniela; Schwarz, Katrin; Hammann-Haenni, Anya; Willers, Joerg; Geldhof, Christine; Prior, John O; Kündig, Thomas M; Michielin, Olivier; Bachmann, Martin F; Speiser, Daniel E (2012). Nano-particle vaccination combined with TLR-7 and -9 ligands triggers memory and effector CD8⁺ T-cell responses in melanoma patients. European Journal of Immunology, 42(11):3049-3061.

Dummer, Reinhard; Quaglino, Pietro; Becker, Jürgen C; Hasan, Baktiar; Karrasch, Matthias; Whittaker, Sean; Morris, Stephen; Weichenthal, Michael; Stadler, Rudolf; Bagot, Martine; Cozzio, Antonio; Bernengo, Maria G; Knobler, Robert (2012). Prospective international multicenter phase II trial of intravenous pegylated liposomal doxorubicin monochemotherapy in patients with stage IIB, IVA, or IVB advanced mycosis fungoides: final results from EORTC 21012. Journal of Clinical Oncology, 30(33):4091-4097.

Dummer, Reinhard; Flaherty, Keith T (2012). Resistance patterns with tyrosine kinase inhibitors in melanoma: new insights. Current Opinion in Oncology, 24(2):150-154.

Shakhova, Olga; Zingg, Daniel; Schaefer, Simon M; Hari, Lisette; Civenni, Gianluca; Blunschi, Jacqueline; Claudinot, Stéphanie; Okoniewski, Michal; Beermann, Friedrich; Mihic-Probst, Daniela; Moch, Holger; Wegner, Michael; Dummer, Reinhard; Barrandon, Yann; Cinelli, Paolo; Sommer, Lukas (2012). Sox10 promotes the formation and maintenance of giant congenital naevi and melanoma. Nature Cell Biology, 14(8):882-890.

Urosevic-Maiwald, Mirjana; Harr, Thomas; French, Lars E; Dummer, Reinhard (2012). Stevens-Johnson syndrome and toxic epidermal necrolysis overlap in a patient receiving cetuximab and radiotherapy for head and neck cancer. International Journal of Dermatology, 51(7):864-867.

Mihic-Probst, Daniela; Ikenberg, Kristian; Tinguely, Marianne; Schraml, Peter; Behnke, Silvia; Seifert, Burkhardt; Civenni, Gianluca; Sommer, Lukas; Moch, Holger; Dummer, Reinhard (2012). Tumor cell plasticity and angiogenesis in human melanomas. PLoS ONE, 7(3):e33571.

Curioni-Fontecedro, Alessandra; Nuber, Natko; Mihic-Probst, Daniela; Seifert, Burkhardt; Soldini, Davide; Dummer, Reinhard; Knuth, Alexander; van den Broek, Maries; Moch, Holger (2011). Expression of MAGE-C1/CT7 and MAGE-C2/CT10 predicts lymph node metastasis in melanoma patients. PLoS ONE, 6(6):e21418.

Civenni, Gianluca; Walter, Anne; Kobert, Nikita; Mihic-Probst, Daniela; Zipser, Marie; Belloni, Benedetta; Seifert, Burkhardt; Moch, Holger; Dummer, Reinhard; van den Broek, Maries; Sommer, Lukas (2011). Human CD271-positive melanoma stem cells associated with metastasis establish tumor heterogeneity and long-term growth. Cancer Research, 71(8):3098-3109.

Nuber, Natko; Curioni-Fontecedro, Alessandra; Matter, Claudia; Soldini, Davide; Tiercy, Jean Marie; von Boehmer, Lotta; Moch, Holger; Dummer, Reinhard; Knuth, Alexander; van den Broek, Maries (2010). Fine analysis of spontaneous MAGE-C1/CT7-specific immunity in melanoma patients. Proceedings of the National Academy of Sciences of the United States of America (PNAS), 107(34):15187-15192.

Walter, Anne; Barysch, Marjam J; Behnke, Silvia; Dziunycz, Piotr; Schmid, Bruno; Ritter, Erika; Gnjatic, Sacha; Kristiansen, Glen; Moch, Holger; Knuth, Alexander; Dummer, Reinhard; van den Broek, Maries (2010). Cancer testis antigens and immunosurveillance in human cutaneous squamous cell and basal cell carcinomas. Clinical Cancer Research, 16(14):3562-3570.

Dragieva, Galya; Hafner, Jürg; Dummer, Reinhard; Schmid-Grendelmeier, Peter; Roos, Malgorzata; Prinz, Bettina M; Burg, Günter; Binswanger, Ulrich; Kempf, Werner (2004). Topical photodynamic therapy in the treatment of actinic keratoses and Bowen's disease in transplant recipients. Transplantation, 77(1):115-121.

Kamarashev, Jivko; Ferrone, Soldano; Seifert, Burkhardt; Böni, Roland; Nestle, Frank O; Burg, Günter; Dummer, Reinhard (2001). TAP1 down-regulation in primary melanoma lesions: an independent marker of poor prognosis. International Journal of Cancer, 95(1):23-28.

Helfenstein, Ulrich; Schüler, Georges (1996). Ein generalisiertes additives Modell (GAM) für die Prognose beim malignen Stage-1-Melanom. In: Dummer, Reinhard; Panizzon, Renato; Burg, Günter. Operative und konservative Dermatoonkologie im interdisziplinären Grenzbereich. Wien: Blackwell, Society for the Study of Evolution, 126-128.

This list was generated on Sun Sep 24 14:12:59 2017 CEST.